Department of Radiation Oncology, Olivia Newton-John Cancer Wellness and Research Centre, Austin Health, Heidelberg, Victoria, Australia.
Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.
J Med Imaging Radiat Oncol. 2022 Aug;66(5):678-687. doi: 10.1111/1754-9485.13381. Epub 2022 Feb 1.
To describe the pattern of the use of advanced radiation therapy (RT) techniques, including intensity-modulated RT (IMRT), volumetric modulated arc therapy (VMAT), and stereotactic body RT (SBRT) for the management of bone metastases (BM), and the associated factors in Victoria.
We used a population-based cohort of patients from the state-wide Victorian Radiotherapy Minimum Data Set (VRMDS) who received RT for BM between 2012 and 2017. The primary outcome was proportion of RT courses using advanced RT techniques. The Cochran-Armitage test for trend was used to evaluate temporal trend in advanced RT use. Multinomial logistic regression was used to identify factors associated with advanced RT use.
A total of 18,158 courses of RT were delivered to 10,956 patients-16,626 (91.6%) courses were 3D conformal RT, 857 (4.7%) IMRT/VMAT and 675 (3.7%) SBRT. There was a sharp increase in IMRT/VMAT use from <1% in 2012-2015, to 10.1% in 2016 and 16.3% in 2017 (P-trend < 0.001). Increase in SBRT use was more gradual, from 1.2% in 2012 to 4.8% in 2016 and 5.5% in 2017 for SBRT (P-trend<0.001). In multivariate analyses, year of RT was the strongest predictor of IMRT/VMAT use (OR = 41; 95%CI = 25-67; P < 0.001, comparing 2012-2013 and 2016-2017). Primary tumour type (prostate cancer) was the strongest predictor of SBRT use (OR = 6.07; 95% CI = 4.19-8.80; P < 0.001).
Overall, there was increasing trend in the use of advanced RT techniques for BM in Victoria, with a distinct pattern for IMRT/VMAT compared with SBRT - SBRT uptake was more gradual while IMRT/VMAT uptake was abrupt, occurring contemporaneously with Medicare Benefit Scheme funding changes in 2016.
描述维多利亚州骨转移(BM)管理中先进放疗技术(RT)的使用模式,包括调强放疗(IMRT)、容积旋转调强放疗(VMAT)和立体定向体部放疗(SBRT),以及相关因素。
我们使用了全州范围内维多利亚州放射治疗最低数据集(VRMDS)中的患者人群队列,这些患者在 2012 年至 2017 年间接受了用于 BM 的 RT。主要结局是使用先进 RT 技术的 RT 课程比例。采用 Cochran-Armitage 趋势检验来评估先进 RT 使用的时间趋势。多变量逻辑回归用于确定与先进 RT 使用相关的因素。
共向 10956 名患者提供了 18158 次 RT 课程,其中 16626 次(91.6%)为 3D 适形 RT,857 次(4.7%)为 IMRT/VMAT,675 次(3.7%)为 SBRT。IMRT/VMAT 的使用急剧增加,从 2012-2015 年的<1%增加到 2016 年的 10.1%和 2017 年的 16.3%(趋势 P<0.001)。SBRT 的使用增加较为渐进,从 2012 年的 1.2%增加到 2016 年的 4.8%和 2017 年的 5.5%(趋势 P<0.001)。多变量分析显示,RT 年份是 IMRT/VMAT 使用的最强预测因子(OR=41;95%CI=25-67;P<0.001,比较 2012-2013 年和 2016-2017 年)。原发肿瘤类型(前列腺癌)是 SBRT 使用的最强预测因子(OR=6.07;95%CI=4.19-8.80;P<0.001)。
总体而言,维多利亚州 BM 中先进 RT 技术的使用呈上升趋势,IMRT/VMAT 与 SBRT 相比具有明显的模式——SBRT 的使用较为渐进,而 IMRT/VMAT 的使用则是突然增加,与 2016 年医疗保险福利计划(Medicare Benefit Scheme)资助变化同时发生。